We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Scientists Prepare Disposable Lab-on-a-Chip for Diagnosis at POC

By LabMedica International staff writers
Posted on 01 Oct 2008
Low-cost, disposable cartridges would allow doctors to perform diagnostic tests at the point-of-care and speed up diagnosis and treatment.

European scientists are rapidly approaching their goal of producing a polymer-based device the size of a credit card that would be able to control the movement of biologic fluids, detect the presence of specific proteins, for example early signs of cancer, and analyze the results.

Scientists from Surface Enhanced Micro Optical Fluidic Systems, a consortium of multidisciplinary expertise divided among eight partners and five European countries, are working towards their goal of low cost disposable cartridges capable of quickly and accurately performing complex medical diagnostic tests. More...


The SEMOFS scientists reported that it has made the greatest progress in two areas--microfluidics and plasmonics. Microfluidics includes techniques for controlling the movement of minute quantities of fluids. The SEMOFS card moves blood, serum, and other fluids through channels slightly wider than a human hair. Once the biologic sample and the fluids necessary to process it have interacted in the proper sequence, the device uses plasmonics to determine if proteins from the sample have bonded to the detecting surfaces inside the card.

The scientists plan to pack everything, light sources and detector, waveguides, and the microfluidic system, into one polymer-based card. The electronics that will read the cards and display the results will be a separate unit. "We are targeting state-of-the-art sensitivities or better,” stated Jerôme Gavillet, the dissemination coordinator of SEMOFS, "in a system that could be available anywhere for less than EUR 50.”

Related Links:
SEMOFS



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.